Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Single cell profiling reveals malignant states and immune landscapes in PCNSL and systemic DLBCL.
PMID 42023148 · PMC13097095 · iScience · 2026 · 8 claims · 8 setups
PCNSL and sDLBCL contain five distinct malignant B-cell subtypes (B0-B4) with discrete differentiation trajectories
-
Has reproduction · 86
Single-cell transcriptome maps of myeloid blood cell lineages in Drosophila.
PMID 32900993 · PMC7479620 · Nature communications · 2020 · 8 claims · 8 setups
Single-cell RNA-seq of developing Drosophila lymph glands resolves heterogeneity of hemocytes and identifies major and sub cell types.
-
Full-text index only
Single-cell spatial transcriptomics reveals tumor microenvironment heterogeneity in primary and lymph node-metastatic small cell lung cancer.
PMID 41916294 · PMC13130650 · Cell reports. Medicine · 2026 · 8 claims · 8 setups
Three malignant subclusters (C5, C6, C9) are enriched in LNM tumors and display distinct metabolic and angiogenic programs alongside spatial immune exclusion
-
Full-text index only
Identification of Cell Subpopulation-Specific Driver Genes Reveals Ideal Candidates for Renal Cell Carcinoma Immunotherapy.
PMID 42074110 · PMC13115843 · International journal of molecular sciences · 2026 · 8 claims · 8 setups
25 immune-related candidate driver genes were identified from tumor, myeloid, and lymphoid cell gene regulatory networks (GRNs) using SCENIC and topological Q statistics.
-
Full-text index only
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.
PMID 41593194 · PMC13004670 · Nature medicine · 2026 · 8 claims · 5 setups
PD-1 blockade induces tumor-specific IgG1+ plasma cell responses that complement cellular immunity and contribute to clinical benefit